Hysterosalpingogram also named by the name uterosalpingography is a radiographic diagnostic study of the shape of fallopian tubes and uterus used to evaluate infertility. Uterine abnormality is a factor contributing to 50% of women with early pregnancy loss and 10% of infertile women. Hence, the assessment of uterus and fallopian tubes is a standardized approach towards infertility assessment. The radio-opaque material injection fills the uterus and fallopian tubes to indicate any spillage of material in the peritoneal cavity and tubal rupture.
Hysterosalpingogram is used in the workup of infertile females and diagnosis of uterine malformations, pelvic inflammatory disease, tubal occlusion and Asherman’s syndrome. The chances of pregnancy increases after hysterosalpingogram as the trained radiographer or an interventional radiologist opens the proximally occluded fallopian tubes. Hysterosalpingogram test can be painful and hence an analgesic may be given before or after the procedure to reduce pain. Some doctors prescribe antibiotics before proceeding with the procedure to reduce the chances of infection.
The changing lifestyles and delayed marriage have all resulted in the increased chances of infertility. Infertility affects around 10% to 15% of couples in the U.S. The diagnosis of infertility is given to a couple who haven’t conceived in a year. The cause of infertility ranges from problem such as hormonal imbalance, fibroids, and cysts to some genetic disorder. The increasing fertility is expected to increase the need for procedures such as hysterosalpingogram bringing in more revenue. In Britain, one in six couple in the country has difficulty in conceiving and the number of couples seeking medical help has also increased dramatically.
The reach of contraceptives is really less in under developed countries such as Uganda and Zambia but in recent years international firms are focusing their attention to reach out to these countries. Moreover, injections are out of reach to many women of rural area as the health clinics providing these facilities are far off. Pfizer along with several global aids group is trying to make a new version of the drug making it available to 69 nations throughout Asia, Africa, Eastern Europe, and Latin America.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22703
In terms of geography, the hysterosalpingogram market has been divided into five regions including North- America, Asia- Pacific and Middle-East & Africa, Latin America and Europe. North America region dominated the hysterosalpingogram market owing the favorable reimbursement policies and government support. Moreover, the United States Equestrian Federation is conducting a public workshop to discuss the use of medroxyprogesterone acetate to clarify the various concerns raised on its use. In developing countries, there is a gap between demand and supply of contraceptives. Many initiatives are taken to supply these countries with the required contraceptives so as to address the rising need of birth control.
Some of the market contributors to the hysterosalpingogram market are Fairview Health Services, Atlantic OB-GYN, TRA-MINW, Shady Grove Fertility, Southwest Medical Center, Summit Medical Group, Reproductive Medicine Institute, Crozer-Keystone Health System, South Florida Institute for Reproductive Medicine and Lake Imaging.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453